FRANCISCO DE PAULA
TELLEZ PEREZ
Profesor asociado de Ciencias de la Salud
Hospital Juan Ramón Jiménez
Huelva, EspañaPublicaciones en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (19)
2023
-
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 10, pp. 2591-2596
2022
-
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use
Journal of Infection, Vol. 85, Núm. 3, pp. 322-326
2021
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
-
Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response
AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127
-
Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 5, pp. e96-e102
-
Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 9, pp. 2375-2379
-
Progression to hepatitis C virus micro-elimination in people living with HIV in Spain
Clinical Microbiology and Infection
2020
2019
-
Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes
Journal of Hepatology
-
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54
-
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
Journal of Hepatology, Vol. 71, Núm. 5, pp. 876-888
-
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection
Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 16-24
2016
2013
-
Short communication: Atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C
AIDS Research and Human Retroviruses, Vol. 29, Núm. 2, pp. 223-225
2012
-
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
AIDS, Vol. 26, Núm. 13, pp. 1721-1724
-
Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis
Liver International
-
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
Hepatology, Vol. 56, Núm. 1, pp. 228-238
2011
-
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 6, pp. 1346-1350
2009
-
Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 4, pp. 445-449